Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

WPD 101

Next Previous
Drug Profile

WPD 101

Alternative Names: WPD-101; WPD101a; WPD101b

Latest Information Update: 11 Jun 2024

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Wake Forest University School of Medicine
  • Developer WPD Pharmaceuticals
  • Class Antineoplastics; Bacterial toxins; Interleukins; Recombinant fusion proteins
  • Mechanism of Action Protein synthesis inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Glioblastoma

Most Recent Events

  • 09 May 2024 Discontinued - Preclinical for Glioblastoma in Poland (Intratumoural) before May 2024 (WPD Pharmaceuticals Website, June 2024)
  • 08 Apr 2024 WPD 101 is still in preclinical phase for Glioblastoma in Poland (Intratumoral) (WPD Pharmaceuticals pipeline, April 2024)
  • 28 Jan 2024 No recent reports of development identified for preclinical development in Glioblastoma in Poland (Intratumoural)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top